AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NEXTEQ PLC

Share Issue/Capital Change Apr 14, 2023

7811_rns_2023-04-14_c0b58b1a-ee07-49ff-80d5-7cc4df5bf73a.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1751W

Quixant PLC

14 April 2023

Quixant plc

("Quixant" or the "Company")

Exercise of options

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, announces that it has applied to the London Stock Exchange for 39,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercises of options over Ordinary Shares ("Options") by two employees of the Company.

Total Voting Rights

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 17 April 2023. On Admission the Company's issued share capital will comprise 66,514,060 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,514,060 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer
Tel: +44 (0)1223 892 696
Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane / Charlotte Sutcliffe (ECM)
Tel: +44 (0) 20 7220 0500
Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts
Tel: +44 (0) 20 7523 8000
Financial PR:

Alma PR

Hilary Buchanan / Kieran Breheny / Will Ellis Hancock
Tel: +44 (0)20 3405 0205

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCIJMATMTABBMJ

Talk to a Data Expert

Have a question? We'll get back to you promptly.